Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Intelligent Bio Solutions (INBS) Operating Leases (2023 - 2025)

Intelligent Bio Solutions has reported Operating Leases over the past 2 years, most recently at $81324.0 for Q2 2024.

For Q2 2024, Operating Leases fell 77.17% year-over-year to $81324.0; the TTM value through Jun 2024 reached $81324.0, down 77.17%, while the annual FY2024 figure was $81324.0, 77.17% down from the prior year.
Operating Leases for Q2 2024 was $81324.0 at Intelligent Bio Solutions, down from $414539.0 in the prior quarter.
Over five years, Operating Leases peaked at $479461.0 in Q4 2023 and troughed at $81324.0 in Q2 2024.